"Hyperandrogenism" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A condition caused by the excessive secretion of ANDROGENS from the ADRENAL CORTEX; the OVARIES; or the TESTES. The clinical significance in males is negligible. In women, the common manifestations are HIRSUTISM and VIRILISM as seen in patients with POLYCYSTIC OVARY SYNDROME and ADRENOCORTICAL HYPERFUNCTION.
Descriptor ID |
D017588
|
MeSH Number(s) |
C12.706.316.064.500 C12.706.316.129.750 C13.351.875.253.064.500 C13.351.875.253.129.750 C16.131.939.316.064.500 C16.131.939.316.129.750 C19.391.119.064.500 C19.391.119.129.750
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hyperandrogenism".
Below are MeSH descriptors whose meaning is more specific than "Hyperandrogenism".
This graph shows the total number of publications written about "Hyperandrogenism" by people in this website by year, and whether "Hyperandrogenism" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2008 | 0 | 1 | 1 |
2012 | 1 | 0 | 1 |
2014 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hyperandrogenism" by people in Profiles.
-
Chin V, Censani M, Lerner S, Conroy R, Oberfield S, McMahon D, Zitsman J, Fennoy I. Gonadal dysfunction in morbidly obese adolescent girls. Fertil Steril. 2014 Apr; 101(4):1142-8.
-
Polotsky AJ, Allshouse AA, Crawford SL, Harlow SD, Khalil N, Kazlauskaite R, Santoro N, Legro RS. Hyperandrogenic oligomenorrhea and metabolic risks across menopausal transition. J Clin Endocrinol Metab. 2014 Jun; 99(6):2120-7.
-
Polotsky AJ, Allshouse A, Crawford SL, Harlow SD, Khalil N, Santoro N, Legro RS. Relative contributions of oligomenorrhea and hyperandrogenemia to the risk of metabolic syndrome in midlife women. J Clin Endocrinol Metab. 2012 Jun; 97(6):E868-77.
-
Levens ED, Whitcomb BW, Csokmay JM, Nieman LK. Selective venous sampling for androgen-producing ovarian pathology. Clin Endocrinol (Oxf). 2009 Apr; 70(4):606-14.
-
Burkman RT. The role of oral contraceptives in the treatment of hyperandrogenic disorders. Am J Med. 1995 Jan 16; 98(1A):130S-136S.
-
Kim JH, Richards CJ, Seibel MM. Proper selection of patients for intermediate-dose pure follicle stimulating hormone. J Reprod Med. 1994 Jan; 39(1):1-5.